Expert - Bruce Jackson

Lake Street Capital Markets

"AST is an early-stage company on its way to becoming a multibillion dollar stem-cell therapy business."

— Bruce Jackson, Lake Street Capital Markets (11/10/15)
more >

— Bruce Jackson, Lake Street Capital Markets (10/12/15)
more >

"MDXG's lawsuit could make Organogenesis vulnerable to market share losses."

— Bruce Jackson, Lake Street Capital Markets (1/2/15)
more >

"Expanding into advanced wound care is a main growth driver for MDXG."

— Bruce Jackson, Lake Street Capital Markets (10/13/14)
more >

Due to permission requirements, not all quotes are shown.